BLEEDING IN RENAL-FAILURE - POSSIBLE ROLE OF VASCULAR PROSTACYCLIN (PGI2)
- 1 January 1979
- journal article
- research article
- Vol. 12 (3) , 127-131
Abstract
Specimens of venous tissues from 25 patients with chronic uremia and 7 patients with acute renal failure generated significantly higher PGI[prostacyclin]-like (platelet aggregation inhibiting) activity than venous tissues from 30 normal subjects. After repeated washings, when this activity could barely be detected in the conrols, pronounced inhibitory activity was still evident in samples containing venous tissues from uremic patients. Both prolonged bleeding times and increased PGI2-like activity returned to normal in 4 acute uremic patients on restoration of their renal function. These findings may be relevant to the pathogenesis of bleeding in renal failure.This publication has 7 references indexed in Scilit:
- Unbalanced prostaglandin synthesis and plasma factors in uraemic bleeding. A hypothesisThrombosis Research, 1978
- Prostacyclin: A Potentially Valuable Agent for Preserving Myocardial Tissue in Acute Myocardial IschemiaScience, 1978
- Bleeding in Renal Failure: Altered Platelet Function in Chronic Uraemia only Partially Corrected by HaemodialysisNephron, 1978
- PROSTACYCLIN-LIKE ACTIVITY AND BLEEDING IN RENAL FAILUREThe Lancet, 1977
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- MALONDIALDEHYDE FORMATION AS AN INDICATOR OF PROSTAGLANDIN PRODUCTION BY HUMAN PLATELETS1976